Identification of Evolutionary Trajectories Associated with Antimicrobial Resistance Using Microfluidics

ACS Infect Dis. 2022 Jan 14;8(1):242-254. doi: 10.1021/acsinfecdis.1c00564. Epub 2021 Dec 28.

Abstract

In vitro experimental evolution of pathogens to antibiotics is commonly used for the identification of clinical biomarkers associated with antibiotic resistance. Microdroplet emulsions allow exquisite control of spatial structure, species complexity, and selection microenvironments for such studies. We investigated the use of monodisperse microdroplets in experimental evolution. Using Escherichia coli adaptation to doxycycline, we examined how changes in environmental conditions such as droplet size, starting lambda value, selection strength, and incubation method affected evolutionary outcomes. We also examined the extent to which emulsions could reveal potentially new evolutionary trajectories and dynamics associated with antimicrobial resistance. Interestingly, we identified both expected and unexpected evolutionary trajectories including large-scale chromosomal rearrangements and amplification that were not observed in suspension culture methods. As microdroplet emulsions are well-suited for automation and provide exceptional control of conditions, they can provide a high-throughput approach for biomarker identification as well as preclinical evaluation of lead compounds.

Keywords: Escherichia coli; antibiotic resistance; doxycycline; experimental evolution; metagenomic deep sequencing; microfluidics.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Drug Resistance, Bacterial
  • Escherichia coli / genetics
  • Escherichia coli Infections*
  • Humans
  • Microfluidics*

Substances

  • Anti-Bacterial Agents